Search for: "Sanofi-Aventis US Inc"
Results 41 - 60
of 160
Sorted by Relevance
|
Sort by Date
18 Aug 2017, 2:15 pm
The Department of Justice announced the settlement on August 17, 2017, of two qui tam cases pending in the District of Massachusetts, United States, et al. ex rel. sanofi-aventis US LLC v. [read post]
9 Aug 2006, 9:46 am
Apotex Inc. must be confident the patent on Plavix will be held invalid. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
15 Mar 2011, 3:52 pm
Judge Susan Illston recently granted summary judgment on a few claims but left others for trial in a massive pharmaceutical patent case between Sanofi-Aventis Deutchland GMBH (Sanofi, plaintiff), Genentech, Inc. [read post]
15 Sep 2010, 2:15 am
GmbH and Sanofi-aventis v. [read post]
15 Jun 2023, 2:20 pm
., Sanofi-Aventis Deutschland GmbH v. [read post]
15 Mar 2021, 5:58 pm
Sanofi-Aventis LLC, 2021 WL 872620 (N.D. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s… [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
12 Mar 2008, 1:00 pm
Sanofi-Aventis, 2008 U.S. [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’… [read post]
23 Jun 2015, 2:20 pm
Sanofi-Aventis, U.S., Inc., 2015 WL 3648911 (D.N.J. [read post]
27 Jul 2010, 4:55 am
Karst – As we thought might happen, Sanofi-aventis U.S. [read post]
16 May 2012, 1:49 pm
On May 7, 2012, Yuan Li, a former research scientist with Sanofi Aventis, who had pled guilty to one count of violating 18 U.S.C. [read post]
26 Aug 2010, 10:01 am
Karst – When we attended the August 17th hearing in Sanofi-aventis U.S. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
18 Oct 2011, 8:31 am
” Sanofi- Aventis v. [read post]
10 Aug 2015, 10:27 am
Sanofi-Aventis, U.S., Inc., No. 14-CV-1423 KM, 2015 U.S. [read post]
23 Jun 2010, 10:28 pm
Patent and Trademark Office (Patent Docs) (Patentology) US: BIO celebrates anniversary of Chakrabarty decision (Patent Docs) Products Allegra (Fexofenadine) – US: Sanofi-Aventis secures injunction against Dr. [read post]
29 Jun 2018, 7:50 am
In 2006, with the encouragement of Sanofi-Aventis, USP began to consider a standard for testing enoxaparin. [read post]
